Melphalan is a chemotherapy drug belonging to the class of nitrogen mustard
alkylating agents. An alkylating agent adds an alkyl group to DNA. It attaches the
Drug type: Melphalan is an anti-cancer ("antineoplastic" or "cytotoxic")
chemotherapy drug. This medication is classified as an "alkylating agent." (For
more detail ...
Jan 23, 2014 ... The chemotherapy drug melphalan can treat myeloma, advanced ovarian cancer
and advanced breast cancer. The possible side effects ...
Jan 3, 2016 ... Alkeran (melphalan) is a drug prescribed for the treatment of multiple myeloma
and ovarian cancer. Side effects of Alkeran include weight loss, ...
Easy to read patient leaflet for melphalan. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Consumer information about the medication MELPHALAN - ORAL (Alkeran),
includes side effects, drug interactions, recommended dosages, and storage ...
Find patient medical information for melphalan oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
An alkylating nitrogen mustard that is used as an antineoplastic in the form of the
levo isomer – melphalan, the racemic mixture – merphalan, and the dextro ...
Melphalan is a cytotoxic medicine which is used in conditions where cells in the
body are rapidly dividing and multiplying, such as in multiple myeloma.
Jun 1, 2015 ... Melphalan, a bifunctional nitrogen mustard-derivative alkylating agent, is the ...
Melphalan inhibits DNA and RNA synthesis via formation of ...